306 related articles for article (PubMed ID: 37954597)
1. Qinhuo Shanggan oral solution resolves acute lung injury by down-regulating TLR4/NF-
Tang S; Liang Y; Wang M; Lei J; Peng Y; Tao Q; Ming T; Yang W; Zhang C; Guo J; Xu H
Front Immunol; 2023; 14():1285550. PubMed ID: 37954597
[TBL] [Abstract][Full Text] [Related]
2. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury.
Zhang Q; Yang C; Ma S; Guo S; Hu X; Zhou Z; Liu Y; Zhang X; Jiang R; Zhang Z; Wen L
J Ethnopharmacol; 2023 Sep; 313():116615. PubMed ID: 37164255
[TBL] [Abstract][Full Text] [Related]
3. Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats.
Wu Y; Huang D; Wang X; Pei C; Xiao W; Wang F; Wang Z
Int Immunopharmacol; 2021 Jul; 96():107621. PubMed ID: 33872850
[TBL] [Abstract][Full Text] [Related]
4. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
Front Immunol; 2022; 13():846384. PubMed ID: 35281058
[TBL] [Abstract][Full Text] [Related]
5. Fortunellin ameliorates LPS-induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF-κB/NLRP3 pathway.
Liu D; Guo R; Shi B; Chen M; Weng S; Weng J
Immun Inflamm Dis; 2024 Mar; 12(3):e1164. PubMed ID: 38501503
[TBL] [Abstract][Full Text] [Related]
6. miRNA-206-3p alleviates LPS-induced acute lung injury via inhibiting inflammation and pyroptosis through modulating TLR4/NF-κB/NLRP3 pathway.
Chen M; Zhang J; Huang H; Wang Z; Gao Y; Liu J
Sci Rep; 2024 May; 14(1):11860. PubMed ID: 38789583
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effect and component analysis of Chaihu Qingwen granules.
Zhou Y; Li QX; Liao ZZ; Liu Y; Ouyang Y; Jiang WJ; Tang MT; Hu JF; Zhang W
J Ethnopharmacol; 2023 Dec; 317():116763. PubMed ID: 37315646
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑223 attenuates LPS‑induced inflammation in an acute lung injury model via the NLRP3 inflammasome and TLR4/NF‑κB signaling pathway via RHOB.
Yan Y; Lu K; Ye T; Zhang Z
Int J Mol Med; 2019 Mar; 43(3):1467-1477. PubMed ID: 30747229
[TBL] [Abstract][Full Text] [Related]
9. The involvement of oxidative stress and the TLR4/NF-κB/NLRP3 pathway in acute lung injury induced by high-altitude hypoxia.
Cao W; Zeng Y; Su Y; Gong H; He J; Liu Y; Li C
Immunobiology; 2024 May; 229(3):152809. PubMed ID: 38788361
[TBL] [Abstract][Full Text] [Related]
10. The Defensive Action of LYRM03 on LPS-Induced Acute Lung Injury by NF-κB/TLR4/NLRP3 Signals.
Wang B; Wang J; Lu D; Qi N; Liu Q
J Invest Surg; 2021 Mar; 34(3):284-296. PubMed ID: 31274341
[TBL] [Abstract][Full Text] [Related]
11. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury.
Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J
Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584
[TBL] [Abstract][Full Text] [Related]
12. miR-16 inhibits NLRP3 inflammasome activation by directly targeting TLR4 in acute lung injury.
Yang Y; Yang F; Yu X; Wang B; Yang Y; Zhou X; Cheng R; Xia S; Zhou X
Biomed Pharmacother; 2019 Apr; 112():108664. PubMed ID: 30784935
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydropalmatine induces the polarization of M1 macrophages to M2 to relieve limb ischemia-reperfusion-induced lung injury via inhibiting the TLR4/NF-κB/NLRP3 signaling pathway.
Wen H; Lu D; Chen H; Zhu Y; Xie Q; Zhang Z; Wu Z
Drug Dev Res; 2022 Sep; 83(6):1362-1372. PubMed ID: 35976115
[TBL] [Abstract][Full Text] [Related]
14. Avanafil as a Novel Therapeutic Agent Against LPS-Induced Acute Lung Injury via Increasing CGMP to Downregulate the TLR4-NF-κB-NLRP3 Inflammasome Signaling Pathway.
Aydin P; Magden ZBA; Uzuncakmak SK; Halici H; Akgun N; Mendil AS; Mokhtare B; Cadirci E
Lung; 2022 Oct; 200(5):561-572. PubMed ID: 36040529
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
[TBL] [Abstract][Full Text] [Related]
16. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X
Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451
[TBL] [Abstract][Full Text] [Related]
17. Yemazhui () ameliorates lipopolysaccharide-induced acute lung injury modulation of the toll-like receptor 4/nuclear factor kappa-B/nod-like receptor family pyrin domain-containing 3 protein signaling pathway and intestinal flora in rats.
Li R; Yang H; Xue Y; Xianqin L
J Tradit Chin Med; 2024 Apr; 44(2):303-314. PubMed ID: 38504536
[TBL] [Abstract][Full Text] [Related]
18. Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS
Zhang C; Wang X; Wang C; He C; Ma Q; Li J; Wang W; Xu YT; Wang T
Front Pharmacol; 2021; 12():790072. PubMed ID: 35002723
[No Abstract] [Full Text] [Related]
19. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
Yang JW; Mao B; Tao RJ; Fan LC; Lu HW; Ge BX; Xu JF
J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368
[TBL] [Abstract][Full Text] [Related]
20. Harmine mitigates LPS-induced acute kidney injury through inhibition of the TLR4-NF-κB/NLRP3 inflammasome signalling pathway in mice.
Niu X; Yao Q; Li W; Zang L; Li W; Zhao J; Liu F; Zhi W
Eur J Pharmacol; 2019 Apr; 849():160-169. PubMed ID: 30716318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
